Accounts payable Accounts receivable, less allowance of $1,741 at July 2, 2011 and $1,799 at April 2, 2011 Accrued income taxes Less: accumulated depreciation Less: accumulated depreciation Accumulated other comprehensive income Additional paid-in capital Non cash items: Adjustments to reconcile net income to net cash provided by operating activities: Stock-based compensation expense recognized Accounts receivable, allowance Amendment Flag Stock options excluded from computation of weighted average shares outstanding Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Applied Critical Care Services Inc ACCS Asset Write down Asset Write down Total assets Total assets Assets [Abstract] ASSETS Total current assets Total current assets Current assets: Assets, Fair Value Disclosure Assets, Fair Value Disclosure, Total Assets, Fair Value Disclosure [Abstract] Assets Maturity period for foreign currency contracts Balance Sheet Location [Domain] BASIS OF PRESENTATION Blood Bank Disposables Blood Bank Disposables Business Acquisition, Acquiree [Domain] Business Acquisition [Axis] Business acquisition cost Business Acquisition [Line Items] Purchase price allocated to customer relationships Purchase price allocated to goodwill Purchase price allocated to other liabilities Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability Accretion of interest expense on contingent consideration ACQUISITIONS Capitalized costs placed into service Total costs capitalized related to in process software development initiatives Cash and cash equivalents Cash and Cash Equivalents at End of Period Cash and Cash Equivalents at Beginning of Year Net Increase/(Decrease) in Cash and Cash Equivalents Net Increase/(Decrease) in Cash and Cash Equivalents Recognized net losses in earnings on cash flow hedges Cash Flow Hedging Non-cash Investing and Financing Activities: Commitments and contingencies (Note 12) COMMITMENTS AND CONTINGENCIES Common stock, par value Common stock, Authorized Common stock, Issued Common stock, outstanding Common stock, $0.01 par value; Authorized - 150,000,000 shares; Issued and outstanding- 25,770,869 at July 2, 2011 and 25,660,393 shares at April 2, 2011 Total comprehensive income Total comprehensive income COMPREHENSIVE INCOME Cost of goods sold Current Fiscal Year End Date Deferred tax asset, net Deferred tax asset, long term Deferred tax liability Long-term deferred tax liability Depreciation and amortization Derivative Assets: Derivative Contract Type [Domain] Derivative Assets Derivative Liabilities Derivative Instrument Risk [Axis] Derivative Instruments, Gain (Loss) by Hedging Relationship [Axis] Derivative Instruments, Gain (Loss) by Hedging Relationship, by Income Statement Location, by Derivative Instrument Risk [Table] Derivative Instruments, Gain (Loss) by Income Statement Location [Axis] Derivative Instruments, Gain (Loss) [Line Items] Amount of Loss Reclassified from AOCI into Earnings (Effective Portion) Amount of losses reclassified to earnings within the next twelve months Amount of Loss Recognized in AOCI (Effective Portion) Amount of Loss Recognized in OCI (Effective Portion) Derivative Liabilities: Derivative [Line Items] DERIVATIVES AND FAIR VALUE MEASUREMENTS Derivatives, Fair Value, by Balance Sheet Location [Axis] Derivatives, Fair Value [Line Items] Derivative [Table] Designated as Hedging Instrument Diagnostics Diagnostics Disclosure - ACQUISITIONS - Additional Information [Abstract] Disclosure - ACQUISITIONS - Additional Information [Abstract] Disclosure - Assumptions Utilized for Estimating Fair Value of Option Grants [Abstract] Disclosure - Assumptions Utilized for Estimating Fair Value of Option Grants [Abstract] Disclosure - CAPITALIZATION OF SOFTWARE DEVELOPMENT COSTS - Additional Information [Abstract] Disclosure - CAPITALIZATION OF SOFTWARE DEVELOPMENT COSTS - Additional Information [Abstract] Disclosure - DERIVATIVES AND FAIR VALUE MEASUREMENTS - Additional Information [Abstract] Disclosure - DERIVATIVES AND FAIR VALUE MEASUREMENTS - Additional Information [Abstract] Disclosure - EARNINGS PER SHARE - Additional Information [Abstract] Disclosure - EARNINGS PER SHARE - Additional Information [Abstract] Disclosure - Effect of Derivative Instruments Designated as Cash Flow Hedges and Those Not Designated as Hedging Instruments [Abstract] Disclosure - Effect of Derivative Instruments Designated as Cash Flow Hedges and Those Not Designated as Hedging Instruments [Abstract] Disclosure - Fair Value of Derivative Instruments as They Appear in Consolidated Balance Sheets [Abstract] Disclosure - Fair Value of Derivative Instruments as They Appear in Consolidated Balance Sheets [Abstract] Disclosure - Financial Assets and Financial Liabilities Measured at Fair Value on a Recurring Basis [Abstract] Disclosure - Financial Assets and Financial Liabilities Measured at Fair Value on a Recurring Basis [Abstract] Disclosure - INCOME TAXES - Additional Information [Abstract] Disclosure - INCOME TAXES - Additional Information [Abstract] Disclosure - Inventories [Abstract] Disclosure - Inventories [Abstract] STOCK-BASED COMPENSATION Disclosure - Product Warranty Liabilities [Abstract] Disclosure - Product Warranty Liabilities [Abstract] Disclosure - Reconciliation of Beginning and Ending Level 3 Liabilities [Abstract] Disclosure - Reconciliation of Beginning and Ending Level 3 Liabilities [Abstract] Disclosure - Reconciliation of Numerators and Denominators of Basic and Diluted Earnings Per Share Computations [Abstract] Disclosure - Reconciliation of Numerators and Denominators of Basic and Diluted Earnings Per Share Computations [Abstract] Disclosure - Revenues from External Customers [Abstract] Disclosure - Revenues from External Customers [Abstract] Disclosure - STOCK-BASED COMPENSATION - Additional Information [Abstract] Disclosure - STOCK-BASED COMPENSATION - Additional Information [Abstract] Disclosure - Summary of Components of Other Comprehensive Income [Abstract] Disclosure - Summary of Components of Other Comprehensive Income [Abstract] Disclosure - Summary of Restructuring Activity [Abstract] Disclosure - Summary of Restructuring Activity [Abstract] Document - Document and Entity Information [Abstract] Document - Document and Entity Information [Abstract] Document Fiscal Period Focus Document Fiscal Year Focus Document Information [Line Items] Document Period End Date Document Type Basic income per share Net income Basic EPS Basic income per common share Diluted income per share Net income Diluted EPS Income per common share assuming dilution EARNINGS PER SHARE ("EPS") Reported tax rate Effect of exchange rates on cash and cash equivalents Accrued payroll and related costs Income tax benefit recognized related to Stock-based compensation Employee Severance Employee stock purchase plan Entities [Table] Entity Central Index Key Entity Common Stock, Shares Outstanding Entity [Domain] Entity Filer Category Entity Registrant Name Equipment and Other Related Equipment and Other Related Excess tax benefit on exercise of stock options Facility Closing Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring Basis [Table] Fair Value, Assets and Liabilities Measured on Recurring Basis [Table] Fair Value, Hierarchy [Axis] Fair Value by Measurement Frequency [Axis] Fair Value, Inputs, Level 1 Fair Value, Inputs, Level 2 Fair Value, Inputs, Level 3 Fair Value Measurements Using Significant Unobservable Inputs (Level 3) Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation Fair Value, Measurement Frequency [Domain] Fair Value, Measurements, Fair Value Hierarchy [Domain] Fair Value, Measurements, Recurring Accretion of interest expense on contingent consideration Change in value Fair Value, Measurement with Unobservable Inputs Reconciliations, Recurring Basis, Liability Value Ending balance Beginning balance Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Intangible assets, amortization Intangible assets, less amortization of $46,707 at July 2, 2011 and $43,827 at April 2, 2011 Foreign Country Designated foreign currency hedge contracts outstanding Foreign Currency Contract, Asset, Fair Value Disclosure Forward currency exchange contracts Foreign Currency Contracts, Liability, Fair Value Disclosure Forward currency exchange contracts Non-designated foreign currency hedge contracts outstanding Foreign Exchange Contract Amount Excluded from Effectiveness Testing Loss/(Gain) on sales of property, plant and equipment Loss/(Gain) on sales of property, plant and equipment Goodwill Gross Profit Gross profit Hedging Designation [Axis] Hedging Designation [Domain] Hedging Relationship [Domain] Hospital Disposables Hospital Disposables Income before provision for income taxes Income before provision for income taxes Income Statement [Abstract] Income Statement and Other Comprehensive Income (Loss) Location [Domain] INCOME TAXES Income Taxes [Line Items] Income Taxes [Line Items] Income taxes paid Income Taxes [Table] Income Taxes [Table] Provision for income taxes Benefit from release of reserves Decrease in accounts payable and accrued expenses Decrease in accounts receivable, net Decrease in accounts receivable, net Increase in inventories Increase in inventories Change in operating assets and liabilities: Decrease in other assets and other long-term liabilities Decrease in other assets and other long-term liabilities Decrease in prepaid income taxes Decrease in prepaid income taxes Interest Expense Interest expense Interest paid Inventory Disclosure [Line Items] Inventory Disclosure [Line Items] Inventory Disclosure [Table] Inventory Disclosure [Table] INVENTORIES Finished goods Inventories, net Inventories, net Raw materials Work-in-process Interest income Money market funds Land, building and building improvements. Land, building and building improvements Legal Entity [Axis] Total liabilities and stockholders' equity Total liabilities and stockholders' equity LIABILITIES AND STOCKHOLDERS' EQUITY Total current liabilities Total current liabilities Current liabilities: Liabilities, Fair Value Disclosure Liabilities, Fair Value Disclosure, Total Liabilities Notes payable and current maturities of long-term debt Fair value of long-term debt obligations Long-term debt, net of current maturities Plant equipment and machinery Net cash provided by/(used in) financing activities Net cash provided by/(used in) financing activities Cash Flows from Financing Activities: Net cash used in investing activities Net cash used in investing activities Cash Flows from Investing Activities: Net cash provided by operating activities Net cash provided by operating activities Cash Flows from Operating Activities: Net income Net income Net Revenues Cost Of Goods Sold And Selling General And Administrative Expense Net revenues, COGS, and SG&A Disclosure of changes in accounting principles including adoption of new accounting pronouncements NEW ACCOUNTING PRONOUNCEMENTS Not Designated as Hedging Instrument Notes to Financial Statements [Abstract] Notes to Financial Statements [Abstract] Office equipment and information technology. Office equipment and information technology Total operating expenses Total operating expenses Operating expenses: Operating income Operating income Operating Segments OrthoPAT OrthoPAT Other Accrued Liabilities Other Accrued Liabilities Other assets: Other long-term assets Foreign currency translation Other comprehensive income: Net change in minimum pension liability, net of tax Net change in minimum pension liability, net of tax Reclassifications into earnings of cash flow hedge (gains)/losses, net of tax Reclassifications into earnings of cash flow hedge (gains)/losses, net of tax Unrealized gain/(loss) on cash flow hedges, net of tax Other Current Assets Other Current Assets Other Expense Other Income Other liabilities Other liabilities - contingent consideration Other long-term liabilities Other income/(expense), net Share repurchase Share repurchase Capital expenditures on property, plant and equipment Capital expenditures on property, plant and equipment Percentage of Net Sales Percentage of sales generated outside the US Plasma Disposables Plasma Disposables Platelet Platelet Prepaid expenses and other current assets Net decrease in short-term loans Proceeds from sale of property, plant and equipment Exercise of stock options Product Liability Contingency [Line Items] Product Liability Contingency [Table] Products and Services [Axis] Products and Services [Domain] Product Warranty Accrual Warranty accrual as of the end of the period Warranty accrual as of the beginning of the period Warranty spending Warranty spending Warranty provision PRODUCT WARRANTIES Total property, plant and equipment Total property, plant and equipment Net property, plant and equipment Net property, plant and equipment Property, plant and equipment: Haemonetics equipment Reconciliation of Revenue from Segments to Consolidated Red Cell Red Cell Payments on long-term real estate mortgage Payments on long-term real estate mortgage Research, development and engineering Capitalized software development costs for ongoing initiatives CAPITALIZATION OF SOFTWARE DEVELOPMENT COSTS REORGANIZATION Restructuring Cost and Reserve [Axis] Restructuring Cost and Reserve [Line Items] Restructuring Reserve Ending balance Beginning balance Cost Incurred Payments Payments Retained earnings Net revenues Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Comprehensive Income (Loss) Schedule of Derivative Instruments, Gain (Loss) in Statement of Financial Performance Schedule of Derivative Instruments in Statement of Financial Position, Fair Value Schedule of Earnings Per Share, Basic and Diluted, by Common Class [Line Items] Schedule of Earnings Per Share, Basic and Diluted, by Common Class [Line Items] Schedule of Earnings Per Share, Basic and Diluted, by Common Class [Table] Schedule of Earnings Per Share, Basic and Diluted, by Common Class [Table] Schedule of Earnings Per Share Reconciliation Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis Schedule of Inventory, Current Schedule of Product Warranty Liability Schedule Of Research And Development [Line Items] Schedule Of Research And Development [Line Items] Schedule Of Research And Development [Table] Schedule Of Research And Development [Table] Schedule of Restructuring and Related Costs [Table] Schedule of Restructuring Reserve by Type of Cost Schedule of Segment Reporting Information, by Segment [Table] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions Segment [Domain] Segment, Geographical [Domain] SEGMENT INFORMATION Segment Reporting Information [Line Items] Selling, general and administrative Stock compensation expense Stock Options Black-Scholes assumptions (weighted average): Dividend yield Expected life (years) Volatility Risk-free interest rate Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Weighted average fair value of options granted Software Solutions Software Solutions Statement, Business Segments [Axis] Statement, Geographical [Axis] Statement [Line Items] Statement of Cash Flows [Abstract] Statement of Financial Position [Abstract] Statement [Table] Total stockholders' equity Total stockholders' equity Stockholders' equity: Stock Issued During Period, Employee Stock Purchase Plans, Price Per Share Shares purchased under the ESPP, value per share Shares purchased under the ESPP Supplemental Disclosures of Cash Flow Information: Surgical Surgical Tax benefit on exercise of stock options Total other assets. Total Other Assets Total other assets Trading Symbol Transfers from inventory to fixed assets. Transfers from inventory to fixed assets for placements of Haemonetics equipment Type of Restructuring [Domain] Unrealized loss from hedging activities Unrealized loss from hedging activities Net effect of common stock equivalents Diluted Diluted weighted average shares Weighted average shares outstanding Basic Basic weighted average shares Weighted average shares